|
奥格列龙市场分析报告
|
Oral Proteins and Peptides Market Forecasts to 2030 – Global Analysis By Product Type (Oral Peptides and Oral Proteins), Drug Type, Dosage Form, Biological Target, Mechanism of Action, Application, End User and By Geography ... announced new phase 2 data for orforglipron, its first nonpeptide oral glucagon ... in the New England Journal of Medicine. Orforglipron met both primary and secondary ...
Type 2 Diabetes Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 ... Lilly and Company revealed that orforglipron, an oral, non-peptide glucagon-like ...
|
|
|